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Only a small proportion of individuals with Mild Cognitive Impairment (MCI) will convert
to dementia. Methods currently available to identify risk for conversion do not combine
enough sensitivity and specificity, which is even more problematic in low-educated popu-
lations. Current guidelines suggest the use of combined markers for dementia to enhance
the prediction accuracy of assessment methods. The present study adhered to this pro-
posal and investigated the sensitivity and specificity of the electrophysiological component
P300 and standard neuropsychological tests to assess patients with Alzheimer’s disease
(AD) and MCI recruited from a low-income country. The neuropsychological battery com-
prised tests of memory, attention, language, praxis, and executive functions.The P300 was
recorded using a classical visual odd-ball paradigm. Three variables were found to achieve
sensitivity and specificity values above 80% (Immediate and Delayed recall of word list –
CERAD – and the latency of P300) for both MCI and AD. When they entered the model
together (i.e., combined approach) the sensitivity for MCI increased to 96% and the speci-
ficity remained high (80%). Our preliminary findings suggest that the combined use of
sensitive neuropsychological tasks and the analysis of the P300 may offer a very useful
method for the preclinical assessment of AD, particularly in populations with low socioe-
conomic and educational levels. Our results provide a platform and justification to employ
more resources to convert P300 and related parameters into a biological marker for AD.
Keywords: Alzheimer’s disease, mild cognitive impairment, event related potentials, P300, neuropsychology, early
detection, preclinical markers
INTRODUCTION
According to Alzheimer’s Disease (AD) International, as many as
28 million of the world’s 36 million people with dementia have
yet to receive a diagnosis, and therefore do not have access to
treatment, information, and care (Alzheimer’s Disease Interna-
tional, 2011). They forecast that dementia will continue to affect
the population worldwide and low-income countries will expe-
rience a more dramatic impact. A factor undermining the early
diagnosis of dementia is the lack of reliable assessment methods
(Sperling et al., 2011). The present study was aimed at investigating
whether the combined use of neuropsychological and electro-
physiological methods (i.e., P300) could help tackle this research
priority. Particularly, this study investigated whether this com-
bined approach would yield a methodology capable of achieving
good classification powers (i.e., sensitivity and specificity) in pop-
ulations with low socio-cultural background such as that found in
Latin American countries (see Ardila et al., 1994).
Alzheimer’s disease is the most common form of dementia
(Blennow et al., 2006). Although memory impairment is its most
salient feature (Greene et al., 1996; Graham et al., 2004; Dudas
et al., 2005; Nestor et al., 2006), the disease often presents with
different neuropsychological phenotypes (Fields et al., 2011). This
heterogeneity also characterizes the preclinical stages of AD [e.g.,
Mild Cognitive Impairment (MCI), Petersen, 2004, 2006; Petersen
and Knopman, 2006; Petersen and Negash, 2008]. For example,
different phenotypes of MCI have been identified and each has
been associated with a different risk for AD (Dubois et al., 2007;
Albert et al., 2011; Jack Jr. et al., 2011; Sperling et al., 2011). The
study of individuals with MCI has shown that those who have
memory impairment as a prominent feature in their cognitive
profile (i.e., Amnestic MCI) have the highest probability of devel-
oping AD in the future (Bozoki et al., 2001; Lopez, 2003; Lopez
et al., 2003; Petersen, 2006; Fields et al., 2011). Therefore, amnes-
tic MCI is a preclinical form of dementia which can offer the best
opportunity to investigate whether the combined use of neuropsy-
chological tests and the P300 can aid in the early identification of
changes suggestive of risk for AD. This was precisely the aim of the
present study.
The presence of different biomarkers may suggest AD but do
not lead to a definite diagnosis of AD (Albert et al., 2011; Jack Jr.
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et al.,2011; Sperling et al., 2011). Neuropsychological testing is cru-
cial within this context. However, available memory tasks have not
yet achieved sufficient diagnosis accuracy (i.e., combine sensitivity
and specificity) as to grant them reliability in the detection of AD
(Lowndes and Savage, 2007; Parra et al., 2010; Didic et al., 2011).
Hence, there is a need for combined assessment tools which can
improve the early diagnosis of dementia (Rachakonda et al., 2004;
Dickerson et al., 2007; Dubois et al., 2007; Burns and Morris, 2008;
Albert et al., 2011; Jack Jr. et al., 2011; Sperling et al., 2011). Event
Related Potentials (ERPs), particularly the P300 wave, has proved
to be sensitive to the early effects of AD (Muir et al., 1988; St Clair
et al., 1988; Wright et al., 1988; Polich, 1989; Pokryszko-Dragan
et al., 2003; Katada et al., 2004; Polich and Corey-Bloom, 2005;
Ally et al., 2006; Bonanni et al., 2010; Lai et al., 2010). Using the
classical odd-ball paradigm (Sutton et al., 1965) the characteris-
tics of the P300 wave that have proved most useful in experimental
and clinical settings are its amplitude and latency. These parame-
ters are thought to be related to early conscious processes involved
in attention and memory control (Donchin and Coles, 1988; Pic-
ton, 1992). As an index of early attentional and selection processes
(i.e., a low-level cognitive function), the P300 component recorded
during a classical odd-ball task does not seem to be reliant on the
level of education of the assessed individual (see O’Donnell et al.,
1995 for an example in schizophrenia). This makes it suitable
to investigate cognitive decline in populations with low average
education.
There is now sufficient evidence to suggest that the latency and
amplitude of the P300 are altered in AD (Polich, 1989; Pokryszko-
Dragan et al., 2003; Katada et al., 2004; Polich and Corey-Bloom,
2005; Ally et al., 2006; Muscoso et al., 2006; Caravaglios et al.,
2008; Bonanni et al., 2010; Lai et al., 2010). Furthermore, evidence
has been accrued suggesting that characteristics of the P300 wave
are also compromised in individuals with MCI (Frodl et al., 2002;
Golob et al., 2002; Bennys et al., 2007; van Deursen et al., 2009;
Lai et al., 2010). Recent studies suggest that the latency and ampli-
tude of the P300 wave might serve as a marker for monitoring the
process through which MCI becomes AD (Golob et al., 2002, 2009;
Papaliagkas et al., 2008; van Deursen et al., 2009). Changes in the
P300 parameters have been identified in carriers of gene mutations
that lead to familial AD almost 10 years before the disease onset
(Golob et al., 2009). Taken together these results suggest that the
P300 could contribute to the assessment of AD.
However, neither the P300 variables nor the neuropsychological
tasks on their own have achieved enough specificity for a particu-
lar type of dementia such as AD (see for example Papaliagkas et al.,
2008 for a report on poor correlations between P300 variables and
other neuropsychological variables). More research is therefore
needed to investigate whether the combined use of sensitive cog-
nitive and biological markers can improve both the predictive and
classification power of available assessment methods. Papaliagkas
et al. (2010) combined the analysis of P300 with quantification
of beta-amyloid (1–42) levels in Cerebrospinal Fluid (CSF). The
authors reported values of sensitivity and specificity for the com-
bination of CSF beta-amyloid levels and P300 latency of 80 and
98% respectively (100 and 89% for the P300 amplitude) in the
discrimination between MCI converters and MCI stable patients.
They suggested that the combination of electrophysiological and
biological markers is a valid approach for the early diagnosis of AD.
However, the analysis of the CSF requires an invasive procedure
which can not be carried out outside health settings. Moreover,
these assessment methods are not widely available in low-income
countries. Computerized neuropsychological tests and portable
systems for the recording of the P300 are now available. They are
relatively inexpensive and can be used flexibly as to match patients’
environment (e.g., testing at home). Considering that P300 have
been found to be sensitive even at very early stages of AD, this
evidence warrants investigation of the subject addressed here.
Studies combining sensitive physiological and cognitive mark-
ers to investigate MCI are scarce. Only a handful of studies have
used the analysis of the P300 component together with neuropsy-
chological tasks to assess MCI and AD, and risk of MCI to AD
conversion (Lastra et al., 2001; Lai et al., 2010; see also Revenok
et al., 2001). These studies have focused on populations with a
socio-cultural background very different to our own (Ardila et al.,
1994), or have assessed groups of individuals with a non-specific
risk for dementia (younger age bands, cortical, and subcortical
dementia, etc.). Thus, the actual value of this combined approach
for the early detection of AD still requires further investigation.
The present study was aimed at investigating this issue in a sample
of MCI patients who are known to be at a high risk for AD and
in a sample of AD patients. Our prediction was that combining
the analysis of the P300 (particularly P300 Latency, see Revenok
et al., 2001 and Lai et al., 2010) with standard neuropsychologi-
cal tests would yield more reliable outcomes in the identification
of MCI and AD (i.e., increase sensitivity). We also predicted that
the combined approach investigated here would also improve the
specificity of the assessment process as the reliance of the P300
paradigm used in this study on the background education is min-
imal hence healthy controls who have limited cognitive reserve
would be better classified (see Nitrini et al., 2009). We are not
aware of previous studies which have addressed these issues with
the methodology proposed here in the assessed population.
MATERIALS AND METHODS
The present study was reviewed and approved by the Ethics Com-
mittee of the Health Faculty at the Surcolombiana University,
Colombia.
PARTICIPANTS
A sample of 30 subjects was selected from the population studied
by Gooding et al. (2006) following the procedures described below.
Participants within each group (i.e., Healthy Controls, MCI, and
AD) were randomly identified from our database. All the partic-
ipants recruited into the study underwent a general interview, a
neurological, and a neuropsychological examination. A multidis-
ciplinary team including neurologists, psychiatrists, psychologists,
and neuropsychologists performed the three assessment steps.
When available, neuroimaging data also entered the diagnostic
process. The team confirmed the diagnosis following the criteria
set by NINCDS-ADRDA Group (McKhann et al., 1984) for AD
and by Petersen (2004) for MCI. To be considered for the MCI
group, participants should have subjective memory complaints
with memory deficits documented by at least one objective mem-
ory test (minimum 1.5 SD below the norms). They should have
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no functional limitations as assessed by the Lawton Scale (see for
example Morris, 2012 for recent suggestions). In addition to these
criteria, participants were excluded from the study if they scored
below 14 on the MMSE, had a previous history of psychiatric or
neurologic disorders, were unable to consent by themselves, or pre-
sented with any kind of addiction or severe visual problems. The
final sample comprised 10 patients with mild to moderate AD, 10
patients with MCI, and 10 healthy controls. All participants gave
informed consent to take part in the study.
Table 1 presents the demographic and psychometric variables
as well as the functional scales for the three groups, together
with the result of statistical comparisons. For the comparison of
these variables we used one-way ANOVA followed by Bonferroni-
corrected post hoc tests. For all the comparisons alpha was set at
0.016 (three contrasts per each demographic variable).
ASSESSMENT
The assessment consisted of two parts, a neuropsychological bat-
tery and the analysis of the latency and amplitude of the P300.
The neuropsychological assessment consisted of tests of Atten-
tion (Trail Making Test Part A and Letter A Cancelation including
Hits and Time in seconds as the dependent variables for both
tests), Memory (Memory for three Phrases, Word List including
Immediate recall, Delayed recall and Recognition, and recall of the
Complex Figure of Rey), Language (Phonological Fluency – Let-
ter FAS and Boston naming test), Constructional Praxis (Copy of
the Complex Figure of Rey), and Executive Functions (Wisconsin
Card Sorting Test including Hits, Number of Categories and Con-
ceptualization, and the Semantic Fluency Test – Animals). For a
more detailed description of these tests and the Spanish norms see
Ardila et al. (1994, 2000).
The ERP P300 component was recorded using the classic Odd-
ball Paradigm with a visual version of the task. A two-channel
DANTEC equipment (KeyPoint 1.0) that includes the P300 mod-
ule was coupled with an external visual stimulator. The external
stimulator was a standard computer running an application cre-
ated add-hoc for the study. This application presented strings of
11 characters (e.g., XXXXXX) in the center of the screen. Each
string was presented for 1 s. In 80% of the trials the characters
were blue (distracter) while in the other 20% they were red (tar-
get). The participants were told to press a button only when the
characters appeared in red color. To obtain the P300 component
AgCl electrodes were placed at Fz (anterior) and Pz (posterior)
according to the 10/20 international system. The impedances were
kept below 10 kΩ. A total of 100 trials were presented which were
averaged out to obtain the P300 wave. We calculated the peak
latency of the P300 and the peak-to-peak amplitude and used
them as the dependent variables.
STATISTICAL ANALYSIS
We performed a sample size calculation based on previous reports
(Lai et al., 2010). Lai et al. (2010) reported that the latency of
the P300 was the most sensitive variable in their analysis. In their
follow up assessment MCI patients showed a latency of the P300
component in Pz of 466.77 (SD= 50.18) while controls showed a
latency of 390.14 (SD= 27.23). This resulted in a large effect size
(Cohen d = 1.9). Considering that in the present study we aimed
at 80% of power with alpha set at 0.05 (critical t = 2.23), the num-
ber of participants required per group would be six. However, we
aimed at a minimum of 10 participants per group as to control
for variability particularly within the control group (considering
the demographic characteristics of the assessed population such
as low education).
For the analysis of the neuropsychological data we used one-
way non-parametric Analysis of Variance (Kruskal–Wallis test)
with the Group factor (Controls vs. MCI vs. AD) as the inde-
pendent variable. Because age was found to be significantly dif-
ferent between AD patients and controls, and marginally different
between Controls and MCI we used it as covariate. For the analy-
sis of the latency and amplitude of the P300 component a mixed
ANCOVA was used with Group (Controls vs. MCI vs. AD) as
the between-subjects factor and Point (Fz vs. Pz) as the repeated
measure. Following ANCOVA, Receiver Operating Characteristics
(ROC) analysis was carried out to calculate the cut-off scores, the
sensitivity and specificity, the Area under the Curve (AUC), and
the 95% Confidence Interval for the neuropsychological and phys-
iological variables (P300) that showed significant group effects.
RESULTS
NEUROPSYCHOLOGY
The results of the analysis of the neuropsychological data are
shown in Table 2. Patients with MCI presented lower performance
Table 1 | Demographic, psychometric and functional variables in the selected sample.
Controls MCI AD Controls vs. MCI Controls vs. AD MCI vs. AD
(n=10) (n=10) (n=10)
Mean (SD) Mean (SD) Mean (SD)
Age 64.70 (4.24) 72.60 (8.11) 74.10 (5.72) 0.026 0.007 1.00
Education (years) 5.30 (4.03) 3.80 (4.39) 1.30 (1.83) 1.00 0.058 0.396
Gender (M/F) 3/7 4/6 4/6 0.85*
MMSE 27.50 (2.95) 26.20 (2.30) 20.80 (4.37) 1.00 <0.001 0.003
GDS 1.10 (0.32) 2.10 (0.32) 2.80 (0.42) <0.001 <0.001 <0.001
Depression (Yesavage) 1.20 (1.14) 3.20 (1.81) 3.40 (2.41) 0.070 0.041 1.00
IADL (Lawton) 8.00 (0.00) 9.40 (2.88) 12.00 (4.90)* 1.00 0.033 0.236
GDS, Global Deterioration Scale; IADL, Instrumental Activities of Daily Living; MMSE, Mini-Mental State Examination. Post hoc contrasts were significant at p<0.016
(Bonferroni-corrected). *Chi-square revealed no significant differences in the sex by group distribution.
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Table 2 | Performance of the three groups on the neuropsychological battery and results of the statistical analysis.
Mean (SD) Kruskal–
Wallis
Adjusted pairwise contrasts
Controls MCI AD p-value Controls vs. MCI Controls vs. AD MCI vs. AD
p-value/d/β p-value/d/β p-value/d/β
TMT (hits) 23.90 (0.32) 22.70 (2.50) 12.00 (3.02) 0.001 ns/0.7/29 0.001/5.2/100 0.001/3.6/100
TMT (time s) 159.0 (60.01) 205.10 (93.54) 423.60 (172.48) 0.001 ns/0.5/23 0.001/2.0/99 0.001/1.6/91
Letter A cancelation (hits) 15.90 (0.32) 15.10 (1.10) 11.50 (4.60) 0.002 ns/1.0/55 0.001/1.5/81 ns/1.1/62
Letter A cancelation (time s) 78.20 (35.72) 71.90 (26.81) 76.10 (61.61) 0.889
Memory for 3 phrases 2.70 (0.48) 2.30 (0.82) 2.30 (0.82) 0.437
World list (immediate) 19.50 (3.21) 14.80 (2.66) 12.00 (4.83) 0.001 0.031/1.6/92 0.001/1.8/97 ns/0.7/33
World list (delayed) 7.10 (2.08) 5.10 (1.10) 2.70 (2.67) 0.003 ns/1.2/70 0.002/1.8/97 ns/1.2/70
World list (recognition) 19.40 (1.07) 19.00 (1.33) 17.00 (3.09) 0.066
Verbal fluency (animals) 19.60 (3.86) 15.20 (3.36) 11.50 (3.92) 0.000 ns/0.3/11 0.001/1.03/60 ns/0.8/42
Verbal fluency (letters) 7.70 (4.37) 5.10 (3.67) 3.10 (3.75) 0.056
Boston naming test 13.30 (1.77) 12.10 (1.60) 10.30 (1.57) 0.005 ns/0.7/32 0.004/1.7/96 ns/1.1/67
Rey figure (copy) 23.75 (9.76) 27.60 (7.75) 12.45 (6.55) 0.004 ns/0.4/15 0.01/1.4/82 0.001/2.1/99
Rey figure (recall) 10.00 (5.42) 13.45 (7.45) 4.65 (4.26) 0.008 ns/0.5/20 ns/1.1/64 0.007/1.4/86
WCST (hits) 19.80 (10.63) 14.40 (4.97) 13.20 (7.79) 0.211
WCST (categories) 2.50 (1.72) 1.30 (0.67) 1.10 (9.83) 0.023 ns/0.6/71 0.033/0.7/84 ns/0.1/7
WCST (conceptualization) 11.60 (11.02) 16.90 (13.14) 15.7 (17.42) 0.318
Adjusted pairwise contrasts were carried out when the main effect of group was found to be significant.
Letter A Cancelation (Hits=number of letters correctly cancelled out of 16); TMT, Trial Making Test (Hits=number of circles correctly connected out of 25);
WCST, Wisconsin Card Sorting Test (Hits=number of cards correctly classified out of 48, Short-version; Conceptualization=number of trials to first category);
p-value/d/β= statistical significance/effect size (Cohen d)/Power (%) for the Bonferroni-corrected age-adjusted post hoc contrasts.
than controls in the following tasks: Recall of Word Lists, Semantic
Verbal Fluency (animals), and the Wisconsin Card Sorting Test
(Hits). However, when age-corrected comparisons were carried
out, memory was the only neuropsychological function that
remained significant across the two groups. This suggests that
the MCI patients presented primarily with an amnesic deficit.
Patients with AD showed lower performance than controls on the
TMT, Letter A Cancelation (Hits), Immediate and Delayed recall
of World Lists, Semantic Verbal Fluency Test (animals), Naming
functions, Number of Categories reached in the WCST and the
copy of the Complex Figure of Rey. These results support the
multi-domain impairment of the AD group. Of note, AD and
MCI patients did not significantly differ in the neuropsychologi-
cal functions found to be impaired in the former group (with the
exception of the TMT test and the copy and recall of the Complex
Figure of Rey). This suggests that MCI patients’ performance on
these tests fell between AD participants and controls (as reflected
by the effect sizes). A combination of subthreshold impairment
in these functions and a limited power due to the current sample
size could explain these outcomes. Of note, this supports the early
stage of AD of the recruited sample.
EVENT RELATED POTENTIALS
Figure 1 shows the average signals of the P300 component for the
three groups as well as the descriptive statistics (mean and SD).
Kolmogorov–Smirnov tests showed that the P300 variables were
normally distributed (p= 0.2 for all). Hence, the validity of the
model described above for the analysis of these variables was con-
firmed. The latency of the P300 component showed a significant
effect of Group [F(2, 27)= 12.48, p< 0.001]. The Recording Point
effect was found not to be significant (Pz vs. Fz) [F(1, 27)= 0.46,
n.s.], nor was the Group by Recording Point interaction signif-
icant [F(2, 27)= 2.11, n.s.]. When age was entered as covariate,
the effect of Group persisted [F(2, 27)= 9.96, p< 0.001]. Post hoc
comparisons with Bonferroni corrections showed that patients
with MCI and AD presented more prolonged latencies than con-
trols (p< 0.05). The difference in the P300 latency between MCI
and AD did not reach the threshold of significance.
The analysis of the amplitude of the P300 component using
the statistical model described above showed a significant effect of
Group [F(2, 27)= 4.63, p< 0.005] a significant effect of Recording
Point [F(1, 27)= 18.91, p< 0.001] but no significant interaction
between these factors [F(2, 27)= 0.65, n.s.]. Post hoc compar-
isons with Bonferroni corrections showed that the P300 ampli-
tude in Fz was smaller in both MCI and AD patients than in
healthy controls. No significant differences were found between
groups in Pz.
The results presented above suggest that memory for word lists
and both P300 parameters (Latency and Amplitude) could not
only separate AD patients from healthy controls but they could
also detect impairments in MCI patients at the group level. These
results lend support to our hypothesis. However, to investigate
whether this classification power also holds at the individual level,
ROC analysis was carried out. For this analysis we chose perfor-
mance on the Immediate and Delayed recall of Word Lists and
both parameters of the P300 recorded in Fz (as no effect of the
Recording Point was found in the latency analysis and the ampli-
tude proved more sensitive at this site). We compared the AUC for
Frontiers in Neurology | Dementia December 2012 | Volume 3 | Article 172 | 4
Parra et al. P300 and neuropsychology in AD and MCI
FIGURE 1 | ERPs (P300) waveforms and parameters (mean and SD) from the three groups (Controls, MCI, and AD) recorded at Fz (anterior) and Pz
(posterior).
the four measures and also calculated the sensitivity and specificity
for each of them.
As Figure 2 and Table 3 show, the latency of the P300 combined
more sensitivity and specificity for MCI and AD than the other two
memory tasks that also proved sensitive in this analysis and in pre-
vious ANCOVA. In fact, the latency of the P300 component proved
to be the most sensitive measure. When the sensitivity and speci-
ficity were calculated based on the values of both the latency of the
P300 and memory for word lists (combined sensitivity and speci-
ficity) using a series testing approach (which considers that both
tests must be positive in order to prompt action, see Schoenbach
and Rosamond, 2001), the sensitivity values for MCI increased
considerably (96%) whereas the specificity remained high (80%).
Of note a cut-of score>441.5 ms for the Latency of P300 resulted
in a sensitivity of 100% and a specificity of 80% for MCI. This
suggests that the combined use of neuropsychological and electro-
physiological functions can offer better solutions for the detection
of cognitive changes associated to MCI and AD.
ADDITIONAL ANALYSIS
Finally, although this was not conceived as a longitudinal study,
we approached our participants to reassess their neuropsycholog-
ical functions. The initial assessment was concluded in 2005. From
September 2011 to March 2012 (between 5 and 6 years after the
first assessment) we were able to contact and reassess four patients
initially seen as MCI and three healthy controls. Two of the initial
MCI patients died in this interval, two had changed residence, one
did not consent to take part in the reassessment, and one could
not be contacted. Of the controls, one died, one did not consent to
participate in the reassessment, and the others could not be con-
tacted. We thought that although this dataset is limited it could
still be informative. These subjects were reassessed using the same
neuropsychological protocol and the criteria for MCI (Petersen,
2004) and AD (McKhann et al., 1984) were applied. Of the four
MCI patients reassessed, two had converted to AD, one returned to
normality, and one had an uncertain diagnosis. The patient with
an uncertain diagnosis showed clear improvement in her global
cognitive functions and other neuropsychological functions such
as memory, attention, and executive function. However, her score
on the IADL scale (Lawton) dropped relative to the first assess-
ment. None of the healthy controls reassessed met MCI or AD
criteria. The P300 data and the neuropsychological scores corre-
sponding to the reassessed participants can be found in Table A1
in Appendix. The two MCI patients who converted to AD showed
the longest latencies of the P300 component relative to the other
reassessed participants. Of note, the MCI patient who returned
to normality and the patient who received an uncertain diagno-
sis during the reassessment showed P300 latencies in the initial
assessment which were within the normal limits.
DISCUSSION
The present study was set out to investigate whether the com-
bined analysis of neuropsychological variables and variables of
the P300 wave would yield classification powers (i.e., sensitiv-
ity and specificity) during the assessment of patients with MCI
and AD better than those reported with each methodology sepa-
rately. This hypothesis was investigated in a population with low
socio-cultural background which is known to pose challenges to
the interpretation of the outcomes of standard neuropsycholog-
ical tasks (see Ardila et al., 1994). Three variables were found to
achieve sensitivity and specificity values above 80% (Immediate
and Delayed recall or word list – CERAD – and the latency of
P300) for both MCI and AD. When they enter the model together
(i.e., combined approach) the sensitivity for MCI increased to 96%
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FIGURE 2 | Results from the ROC analysis carried out with neuropsychological and physiological variables that were found to be significant in group
comparisons.
Table 3 | Results of the ROC analysis with the variables which resulted in significant differences in group comparisons.
Controls vs. MCI Controls vs. AD
Cut-off AUC SE CI 95% Sensitivity (%) Specificity (%) AUC SE CI 95% Sensitivity (%) Specificity (%)
Word list (immediate) ≤17 0.88 0.08 0.65–0.98 80 80 0.92 0.06 0.71–0.99 90 80
Word list (delayed) ≤5 0.78 0.12 0.54–0.93 80 80 0.90 0.07 0.68–0.99 80 80
Lat P300 FZ >465.5 0.97 0.03 0.78–1.00 80 100 1.00 0.00 0.83–1.00 100 100
Amp P300 FZ ≤4.4 0.84 0.09 0.60–0.96 70 70 0.80 0.11 0.56–0.94 80 70
and the specificity remained high (80%). These results lend sup-
port to our hypotheses. We now discuss the implications that these
findings have for the assessment of MCI and AD.
The literature on AD and MCI reporting on the combined use
of neuropsychological and psychophysiological tests is scarce. Las-
tra et al. (2001) reported findings similar to our own (see also Lai
et al., 2010). These authors concluded that the latency of P300
is a useful tool in the early diagnosis of AD. This suggestion was
supported by the observation of individuals with prolonged P300
latencies, who despite scoring 30 points on the MMSE, later devel-
oped AD. Recent findings of abnormal P300 parameters (i.e., long
latencies and small amplitudes) in asymptomatic carriers of a gene
mutation which leads to familial AD (Golob et al., 2009) almost
10 years before the disease onset support the validity of this test
as a preclinical psychophysiological marker for AD. Neuropsycho-
logical tests and P300 variables have been used in combination for
the evaluation of the therapeutic response to anticholinesterase
drugs in patients with AD (Werber et al., 2001, 2003; Onofrj
et al., 2002; Katada et al., 2003; Paci et al., 2006). However, the
evidence provided by these earlier studies comes from rather het-
erogeneous (i.e., wide age ranges, different forms of dementia)
and non-representative samples (e.g., with a level of education
much higher than that observed in Latin American countries). The
present study focused on a relatively small but more homogenous
sample of amnestic MCI patients whose age was closer to that
known to be associated with late-onset sporadic AD and whose
education truly reflects the level reached by individuals of this age
band in Latin American countries. This evidence is lacking in the
literature concerning early detection of AD (Doraiswamy et al.,
1995; Hong et al., 2011; see also Ardila et al., 1994).
One other study which is relevant to this discussion is one car-
ried out by Lai et al. (2010). They also investigated the value of
combining the study of the P300 with neuropsychological vari-
ables in patients with AD and MCI. They reported results similar
to ours in a relatively larger group of patients. It is worth not-
ing that the average education of their patients was 7.15 (5.03)
and 9.89 (5.15) for AD and MCI respectively. This is much higher
that the average education of our patients. However, the outcomes
from both studies are similar. It is known that performance on tra-
ditional neuropsychological tests is highly sensitive to the subject’s
educational level. For example in the present study the average
MMSE value for the controls was 27.5. Other studies have observed
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this score in MCI patients. This may reflect, to a large extent, the
low educational level of the population assessed in the present
study and the sensitivity of adapted tests to this factor. Therefore,
the results presented here suggest that the use of the P300 in the
assessment of AD could overcome one of the most challenging
issues in neuropsychological testing settings; that is, the cultural
background of the assessed population (Ardila et al., 1994).
The electrophysiological component P300 recorded with the
odd-ball paradigm presented here appears to be insensitive to
trans-cultural variations. For example, Lai et al. (2010) studied
healthy older adults whose mean age was in a range similar to that
of our controls [Lai et al.: 64.79 (7.75); our controls: 64.70 (4.24)].
However, their controls had more years of education than our con-
trols [Lai et al.: 9.70 (4.16); our controls: 5.30 (4.03)]. Considering
that Lai et al. used auditory stimulation which is known to lead to
faster P300 latencies in adults than visual stimulation (see Squires
et al., 1977; Johnson Jr., 1989), we could argue that the control par-
ticipants of these two studies show very similar P300 latencies [Lai
et al.: 404.00 (32.14); our controls: 445.13 (27.0)]. These groups
were recruited in countries with a very different socio-cultural
background thus suggesting that the P300 component might not
vary significantly as functions of the background education. This
renders the analysis of the P300 a very useful tool for assessment
across cultures and countries.
A potential account for the lack of sensitivity of the latency of
the P300 component to the background education could be found
at a cognitive level. This ERP provides a measure of the time taken
for stimulus evaluation and classification but is relatively indepen-
dent of response selection and execution processes (Kutas et al.,
1977; McCarthy and Donchin, 1981). Hence, the P300 taxes early
attentional processes involved in memory functions which operate
at a low demand level. This may explain why the specificity of the
latency of the P300 in the small sample of healthy older adults, MCI
and AD patients assessed here was 100% as healthy older adults
with low cognitive reserve do not show decline in these early cogni-
tive processes. Tests such as free recall of word lists do pose greater
demands both on cognitive processing and on the background
education (Ardila et al., 1994). As AD impacts on early top-down
attentional mechanisms from its preclinical stages (Rapp and Reis-
chies,2005; Li et al.,2011; Olichney et al., 2011), such an assessment
would identify early cognitive decline that is not accounted for by
limited cognitive reserves. This evidence together with our find-
ings suggest that the combined analysis of the P300 and sensitive
neuropsychological variables would yield more reliable assessment
methods which can tackle important challenges in current clinical
settings in a globalized world. If we also consider the low cost of
this technique compared to, neuroimaging techniques (fMRI, PET
or SPECT), the use of these combined tools in the evaluation of
AD and MCI appears to be feasible. Nevertheless, the diagnosis of
dementia is a clinical one and therefore the use of the P300 for
such purposes will always depend on how well its outcomes fit
within the general clinical assessment.
One potential criticism to our study is the small sample size. To
address this issue, we have undertaken a number of a priori and
post hoc analyses to show that this should not limit the validity of
the results presented here. Despite the relatively small sample used
in this study, the results were statistically significant and suggest
that patients with MCI could be better classified if neuropsycho-
logical and P300 variables are considered together. For example
the sensitivity for this group increased from 80% for the Recall
of Word List and 80% for the P300 Latency, to 96% when the
results of these tests were jointly analyzed. The follow up data
from the four MCI patients also suggest that when this clinical
category is accompanied by abnormal P300 parameters, the likeli-
hood of progressing toward AD is higher than when normal P300
parameters are observed at baseline. Future longitudinal studies
should further investigate this preliminary observation. Our data
fit recent suggestions of using multiple biomarkers to increase the
sensitivity and specificity of detection methods for neurodegen-
erative dementias in general and AD in particular (Rachakonda
et al., 2004). While the combined analysis of the latency of the
P300 and memory for word lists considerably boosted the sen-
sitivity of the assessment method, it did not impact to the same
extent on the specificity which, although high (80%), was kept at
the level of the neuropsychological variable. The combined use of
measures from different levels (neuropsychology and neurophys-
iology) implies a more adequate integrated approach to AD and
MCI research (Kuljis, 2009). For example, clinicians could focus
on the combined approach for detection (i.e., sensitivity) and give
more weight to the P300 latency in the separation of healthy from
pathological aging (i.e., specificity).
Moreover, although high density arrays are currently available,
we chose for this study only two recording sites (i.e., Pz and Fz).
These have been suggested as the locations where the P300 com-
ponent shows its optimal parameters (i.e., latency and amplitude;
Osawa, 2001). This very simple, easy to apply, and inexpensive
method proved sufficient and would allow adequate recording
and later comparison with other neuropsychological variables in
any clinical research settings. Finally, we have identified significant
P300 changes and poor memory performance in a small group
of MCI patients who, according to their profile, presented with
the amnestic form of cognitive impairment. This is known to be
the form of MCI that most commonly leads to AD (Bozoki et al.,
2001; Lopez, 2003; Lopez et al., 2003; Fields et al., 2011). However,
it is known that not all MCI patients will eventually convert to
AD (Lonie et al., 2010). Although the P300 parameters deteriorate
as AD progresses (Ball et al., 1989), this component has not been
extensively used to monitor longitudinally MCI or AD patients.
Therefore, future studies should address whether the combined
approach proposed here could help predict MCI to AD conversion
thus permitting its use as a cognitive/functional biomarker for AD.
CONCLUSION
We have combined the analysis of the P300 and standard neuropsy-
chological variables to assess a sample of patients with MCI and
AD taken from a Latin American population which has a socio-
demographic structure typical of low-income countries and which
had not been assessed before using this methodological approach.
We have found that this combined approach can provide valu-
able information for the detection and evaluation of patients with
MCI and AD. Our preliminary findings suggest that in populations
with low socioeconomic and educational levels, the combined use
of these techniques may offer a very useful method for the pre-
clinical assessment of AD. Our results provide a platform and
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justification to employ more resources to convert P300 and related
parameters into an accepted biological marker for AD. This would
allow the definition of cut-off values which can help in the dis-
tinction between normal and pathological aging (e.g., indicators
of neurodegeneration). Moreover, these norms would permit an
easy, inexpensive, and objective diagnosis as well as longitudinal
assessment of larger samples of MCI patients.
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